
‘Dragon Man' DNA revelation puts a face to a mysterious group of ancient humans
CNN —
An enigmatic skull recovered from the bottom of a well in northeastern China in 2018 sparked intrigue when it didn't match any previously known species of prehistoric human. Now, scientists say they have found evidence of where the fossil fits, and it could be a key piece in another cryptic evolutionary puzzle.
After several failed attempts, the researchers managed to extract genetic material from the fossilized cranium — nicknamed Dragon Man — linking it to an enigmatic group of early humans known as Denisovans. A dozen or so Denisovan fossilized bone fragments had previously been found and identified using ancient DNA. But the specimens' small size offered little idea of what this shadowy population of ancient hominins looked like, and the group has never been assigned an official scientific name.
Scientists typically consider skulls, with telltale bumps and ridges, the best type of fossilized remains to understand the form or appearance of an extinct hominin species. The new findings, if confirmed, could effectively put a face to the Denisovan name.
'I really feel that we have cleared up some of the mystery surrounding this population,' said Qiaomei Fu, a professor at the Institute of Paleontology and Paleoanthropology, part of the Chinese Academy of Sciences in Beijing, and lead author of the new research. 'After 15 years, we know the first Denisovan skull.'
Denisovans were first discovered in 2010 by a team that included Fu — who was then a young researcher at the Max Planck Institute for Evolutionary Anthropology in Leipzig, Germany — from ancient DNA contained in a pinkie fossil found in Denisova Cave in the Altai Mountains of Russia. Additional remains unearthed in the cave, from which the group gets its name, and elsewhere in Asia continue to add to the still-incomplete picture.
The new research, described in two scientific papers published Wednesday, is 'definitely going to be among, if not the, biggest paleoanthropology papers of the year,' and will spur debate in the field 'for quite some time,' said Ryan McRae, a paleoanthropologist at the Smithsonian National Museum of Natural History in Washington, DC, who was not involved in the studies.
The findings could help fill in gaps about a time when Homo sapiens weren't the only humans roaming the planet — and teach scientists more about modern humans. Our species once coexisted for tens of thousands of years and interbred with both Denisovans and Neanderthals before the two went extinct. Most humans today carry a genetic legacy of those ancient encounters. Neanderthal fossils have been the subject of study for than a century, but scant details are known about our mysterious Denisovan cousins, and a skull fossil can reveal a great deal.
Long in the tooth
A laborer in the city of Harbin in northeastern China discovered the Dragon Man skull in 1933. The man, who was constructing a bridge over the Songhua River when that part of the country was under Japanese occupation, took home the specimen and stored it at the bottom of a well for safekeeping.
The man never retrieved his treasure, and the cranium, with one tooth still attached in the upper jaw, remained unknown to science for decades until his relatives learned about it before his death. His family donated the fossil to Hebei GEO University, and researchers first described it in a set of studies published in 2021 that found the skull to be at least 146,000 years old.
The researchers argued that the fossil merited a new species name given the unique nature of the skull, naming it Homo longi — which is derived from Heilongjiang, or Black Dragon River, the province where the cranium was found. Some experts at the time hypothesized that the skull might be Denisovan, while others have lumped the cranium in with a cache of difficult-to-classify fossils found in China, resulting in intense debate and making molecular data from the fossil particularly valuable.
Given the skull's age and backstory, Fu said she knew it would be challenging to extract ancient DNA from the fossil to better understand where it fit in the human family tree. 'There are only bones from 4 sites over 100,000 (years old) in the world that have ancient DNA,' she noted via email.
Fu and her colleagues attempted to retrieve ancient DNA from six samples taken from Dragon Man's surviving tooth and the cranium's petrous bone, a dense piece at the base of the skull that's often a rich source of DNA in fossils, without success.
The team also tried to retrieve genetic material from the skull's dental calculus — the gunk left on teeth that can over time form a hard layer and preserve DNA from the mouth. From this process, the researchers managed to recover mitochondrial DNA, which is less detailed than nuclear DNA but revealed a link between the sample and the known Denisovan genome, according to one new paper published in the journal Cell.
'Mitochondrial DNA is only a small portion of the total genome but can tell us a lot. The limitations lie in its relatively small size compared to nuclear DNA and in the fact that it is only inherited from the matrilineal side, not both biological parents,' McRae said.
'Therefore, without nuclear DNA a case could be made that this individual is a hybrid with a Denisovan mother, but I think that scenario is rather less likely than this fossil belonging to a full Denisovan,' he added.
Mounting evidence
The team additionally recovered protein fragments from the petrous bone samples, the analysis of which also suggested the Dragon Man skull belonged to a Denisovan population, according to a separate paper published Wednesday in the journal Science.
Together, 'these papers increase the impact of establishing the Harbin cranium as a Denisovan,' Fu said.
The molecular data provided by the two papers is potentially very important, said anthropologist Chris Stringer, research leader in human origins at London's Natural History Museum.
'I have been collaborating with Chinese scientists on new morphological analyses of human fossils, including Harbin,' he said. 'Combined with our studies, this work makes it increasingly likely that Harbin is the most complete fossil of a Denisovan found so far.'
However, Xijun Ni, a professor at the Institute of Vertebrate Paleontology and Paleoanthropology in Beijing who, along with Stringer, worked on the initial Dragon Man research but not the latest studies, said that he is cautious about the outcome of the two papers because some of the DNA extraction methods used were 'experimental.' Ni also said he finds it strange that DNA was obtained from surface dental calculus but not inside the tooth and petrous bone, given that the calculus appeared to be more exposed to potential contamination.
Nonetheless, he added that he thinks it is likely the skull and other fossils identified as Denisovan are from the same human species.
The goal in using a new extraction approach was to recover as much genetic material as possible, Fu explained, adding that the dense crystalline structure of dental calculus may help prevent the host DNA from being lost.
The protein signatures Fu and her team recovered indicated 'a Denisovan attribution, with other attributions very unlikely,' said Frido Welker, an associate professor of biomolecular paleoanthropology at the University of Copenhagen's Globe Institute in Denmark. Welker has recovered Denisovan proteins from other candidate fossils but was not involved in this research.
'With the Harbin cranium now linked to Denisovans based on molecular evidence, a larger portion of the hominin fossil record can be compared reliably to a known Denisovan specimen based on morphology,' he said.
A name and a face for Denisovans
With the Dragon Man skull now linked to Denisovans based on molecular evidence, it will be easier for paleoanthropologists to classify other potential Denisovan remains from China and elsewhere. McRae, Ni and Stringer all said they thought it was likely that Homo longi would become the official species name for Denisovans, although other names have been proposed.
'Renaming the entire suite of Denisovan evidence as Homo longi is a bit of a step, but one that has good standing since the scientific name Homo longi was technically the first to be, now, tied to Denisovan fossils,' McRae said. However, he added that he doubts the informal name of Denisovan is going anywhere anytime soon, suggesting it might become shorthand for the species, as Neanderthal is to Homo neanderthalensis.
The findings also make it possible to say a little more about what Denisovans might have looked like, assuming the Dragon Man skull belonged to a typical individual. According to McRae, the ancient human would have had very strong brow ridges, brains 'on par in size to Neanderthals and modern humans' but larger teeth than both cousins. Overall, Denisovans would have had a blocky and robust-looking appearance.
'As with the famous image of a Neanderthal dressed in modern attire, they would most likely still be recognizable as 'human,'' McRae said.
'They are still our more mysterious cousin, just slightly less so than before,' he added. 'There is still a lot of work to be done to figure out exactly who the Denisovans were and how they are related to us and other hominins.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Fast Company
2 hours ago
- Fast Company
How China is leading the humanoid robots race
I've worked at the bleeding edge of robotics innovation in the United States for almost my entire professional life. Never before have I seen another country advance so quickly. In the span of the last few years, China has overtaken the U.S. as the leader in the robotics race, especially when it comes to humanoid robots designed to mimic the human body and behavior. Earlier this year China literally raced robots against human counterparts, and they show no sign of slowing down. While AI steals the investment and media spotlight, the competition for humanoid robotics supremacy has been quietly accelerating for 50 years, and we're now on the cusp of a momentous breakthrough. Mass-produced humanoid robots may reach us within the next 3–5 years, and the market is predicted to grow to $38B within just 10 years. China is poised to capture the lion's share of this industry: Morgan Stanley found that 56% of robotics companies are already based there. However, this competition isn't just about market share—it's about industrial supremacy. Fixed industrial robots now operate with productivity rates estimated to be 10 times that of humans, working almost 24/7 with virtually no errors. In this new era of free-moving humanoid robots, adaptable machines will navigate entire factory floors with equal precision and even higher productivity rates than their fixed (and human) counterparts. American companies like Boston Dynamics are building impressive prototypes but those don't win industrial wars, production does. If the U.S. continues to lag behind in the robotics race, American businesses will face increased supply chain dependence on China and citizens could see wage stagnation and job losses to robotics leaders overseas. I witnessed the U.S. lead the world in robotic advancements. Two of my humanoid robots went into space; one called 'Robonaut' now lives in the Smithsonian. Over the past decade, our momentum has slowed. To take back robotics supremacy, the U.S. must overcome four critical hurdles that could cost us this race. Why the U.S. Isn't 'All-In' on Humanoids Yes, Chinese robotics startups are benefiting from established supply chains, local adoption opportunities, and strong national government support, but nagging domestic problems are holding the United States back, regardless of any other country's advancements. First, we're battling our own cultural fears. There's a prevailing anxiety that robots will replace human jobs, particularly in factories. While massive change in manufacturing is fast approaching, the fear of replacement is not only wrong—it's counterproductive. Humanoid robots excel at 'dirty, dark, and dangerous' jobs that often lack willing human labor anyway. To overcome U.S. cultural fears around robotics, we must think of robots not as standing in our place but standing by our sides. WWII was won as much on the mechanized manufacturing floor as on the battlefield and novel machines were essential to winning the space race. When Robonaut shook hands with a fellow astronaut aboard the International Space Station, it was proof that robots can and should support human work, not compete with it. Second, we're not cultivating the people behind the humanoids. The real challenge in winning the humanoid race isn't job displacement; it's the massive lack of skilled domestic workers to develop, operate, and maintain advanced robotics. At Texas A&M, I teach brilliant students ready to tackle real-world problems with robots. Educating the workforce about how to leverage robots will empower the next generation and dispel fear. However, across the country, preparation for careers in STEM is lacking. We need more accessible science programs, apprenticeships, and pathways into robotics now. Third, the economics still intimidate us. Developing humanoid robots involves significant upfront costs and still faces expensive technical hurdles, including improving spatial awareness and task adaptability. But here's what the bean counters are missing: once mass production kicks in, the cost of robot labor could plummet from $10 to just $0.25 per hour in as little as 10 years. The industry will transform overnight and whichever country controls this shift owns the future of manufacturing. Focusing on the future affordability of robot labor will incentivize both the private and public sector to invest now. Fourth, our policy framework is falling behind. While the U.S. offers some incentives for research and innovation, they pale in comparison to China's commitment. The Chinese government has poured over $20 billion into robotics and next-generation technologies, providing subsidies for startups and covering costs for equipment and talent acquisition. They're projected to match U.S. robotics research and development levels by 2034. Meanwhile, current U.S. tax code continues to disincentivize longer-term innovation projects by forcing companies to pay more up front for R&D. As the U.S. federal government increasingly overlaps its ambitions with AI tech companies, so too must it champion the development of humanoid robots as a national security and productivity imperative. How America Can Take The Lead Again In tandem with overcoming these inherent challenges, the U.S. must seize two unique opportunities that offer a high return on investment and a clear path to victory. Humanoid robots can maintain our edge in advanced manufacturing. Humanoids integrated with AI and embedded into the internet of things will create smart factories that enhance precision, improve product quality, and accelerate production times. The U.S. currently leads the world in the development of smart textiles —humanoid robots could accelerate production to maintain this advantage. Warehouses offer an arena for rapid humanoid adoption. The number of warehouses across the U.S. continues to expand, with Amazon recently announcing plans for dozens more across rural areas. Our vast network of warehouses is primed for humanoid robots to revolutionize its operations by automating sorting, packing, and transport alongside humans to boost efficiency and slash costs. These aren't theoretical applications: they're already being tested at sites like BMW's South Carolina plant, where robotics partners are deployed for logistics and warehousing tasks. These deployments leverage our existing strengths in technology and innovation while addressing real, immediate market needs. We don't need to wait for the perfect humanoid robot—we can start dominating these sectors today and build from there. This race not just about machines; it's about maintaining U.S. leadership in technology, safety, and industrial strength. If we want the next generation of robotics to serve American interests, we must act now or be left standing on the sidelines of the next industrial revolution. During my two decades at NASA, I saw what American innovators can achieve when given a mission. We sent robots to the Moon, Mars, and into orbit—not because it was easy, but because we believed it mattered for future generations. That same spirit must drive our investment in humanoid robotics today so we can cross the finish line first tomorrow.
Yahoo
8 hours ago
- Yahoo
Rare wooden tools from Stone Age China reveal plant-based lifestyle of ancient lakeside humans
Ancient wooden tools found at a site in Gantangqing in southwestern China are approximately 300,000 years old, new dating has shown. Discovered during excavations carried out in 2014–15 and 2018–19, the tools have now been dated by a team of archaeologists, geologists, chronologists (including me) and paleontologists. The rare wooden tools were found alongside an assortment of animal and plant fossils and stone artifacts. Taken together, the finds suggest the early humans at Gantangqing were surprisingly sophisticated woodworkers who lived in a rich tropical or subtropical environment where they subsisted by harvesting plants from a nearby lake. Wood usually decomposes relatively rapidly due to microbial activity, oxidation, and weathering. Unlike stone or bone, it rarely survives more than a few centuries. Wood can only survive for thousands of years or longer if it ends up buried in unusual conditions. Wood can last a long time in oxygen-free environments or extremely dry areas. Charred or fire-hardened wood is also more durable. At Gantangqing, the wooden objects were excavated from low-oxygen clay-heavy layers of sediment formed on the ancient shoreline of Fuxian Lake. Wooden implements are extremely rare from the Early Palaeolithic period (the first part of the 'stone age' from around 3.3 million years ago until 300,000 years ago or so, in which our hominin ancestors first began to use tools). Indeed, wooden tools more than even 50,000 years old are virtually absent outside Africa and western Eurasia. As a result, we may have a skewed understanding of Palaeolithic cultures. We may overemphasise the role of stone tools, for example, because they are what has survived. The new excavations at Gantangqing found 35 wooden specimens identified as artificially modified tools. These tools were primarily manufactured from pine wood, with a minority crafted from hardwoods. Some of the tools had rounded ends, while others had chisel-like thin blades or ridged blades. Of the 35 tools, 32 show marks of intentional modification at their tips, working edges, or bases. Two large digging implements were identified as heavy-duty digging sticks designed for two-handed use. These are unique forms of digging implements not documented elsewhere, suggesting localised functional adaptations. There were also four distinct hook-shaped tools — likely used for cutting roots — and a series of smaller tools for one-handed use. Nineteen of the tools showed microscopic traces of scraping from shaping or use, while 17 exhibit deliberately polished surfaces. We also identified further evidence of intensive use, including soil residues stuck to tool tips, parallel grooves or streaks along working edges, and characteristic fracture wear patterns. The tools from Gantangqing are more complete and show a wider range of functions than those found at contemporary sites such as Clacton in the UK and Florisbad in South Africa. The team used several techniques to figure out the age of the wooden tools. There is no way to determine their age directly, but we can date the sediment in which they were found. Using a technique called infrared stimulated luminescence, we analysed more than 10,000 individual grains of minerals from different layers. This showed the sediment was deposited roughly between 350,000 and 200,000 years ago. We also used different techniques to date a mammal tooth found in one of the layers to roughly 288,000 years old. This was consistent with the mineral results. Next we used mathematical modelling to bring all the dating results together. Our model indicated that the layers containing stone tools and wooden implements date from 360–300,000 years ago to 290–250,000 years ago. Our research indicates the ancient humans at Gantangqing inhabited a warm, humid, tropical or subtropical environment. Pollen extracted from the sediments reveals 40 plant families that confirm this climate. Plant fossils further verify the presence of subtropical-to-tropical flora dominated by trees, lianas, shrubs and herbs. Wet-environment plants show the local surroundings were a lakeside or wetlands. Animal fossils also fit this picture, including rhinoceros and other mammals, turtles and various birds. The ecosystem was likely a mosaic of grassland, thickets and forests. Evidence of diving ducks confirms the lake must have been at least 2–3 metres deep during human occupation. The site contained evidence of plants such as storable pine nuts and hazelnuts, fruit trees such as kiwi, raspberry-like berries, grapes, edible herbs and fern fronds. There were also aquatic plants that would have provided edible leaves, seeds, tubers and rhizomes. These were likely dug up from shallow mud near the shore, using wooden tools. These findings suggest the Gantangqing hominins may have made expeditions to the lake shore, carrying purpose-made wooden digging sticks to harvest underground food sources. To do this, they would have had to anticipate seasonal plant distributions, know exactly what parts of different plants were edible, and produce specialised tools for different tasks. The wooden implements from Gantangqing represent the earliest known evidence for the use of digging sticks and for the exploitation of underground plant storage organs such as tubers within the Oriental biogeographic realm. Our discovery shows the use of sophisticated wood technology in a very different environmental context from what has been seen at sites of similar age in Europe and Africa. The find significantly expands our understanding of early hominin woodworking capabilities. The hominins who lived at Gantangqing appear to have lived a heavily plant-based subsistence lifestyle. This is in contrast to colder, more northern settings where tools of similar age have been found (such as Schöningen in Germany), where hunting large mammals was the key to survival. The site also shows how important wood – and perhaps other organic materials – were to 'stone age' hominins. These wooden artifacts show far more sophisticated manufacturing skill than the relative rudimentary stone tools found at sites of similar age across East and Southeast Asia. This article is republished from The Conversation. It was written by: Bo Li, University of Wollongong; Jianhui Liu, Yunnan Provincial Institute of Cultural Relics and Archaeology; Robin Dennell, University of Sheffield, and Xing Gao, Chinese Academy of Sciences Read more: Queen Hatshepsut's statues were destroyed in ancient Egypt – new study challenges the revenge theory Trump's worldview is causing a global shift of alliances – what does this mean for nations in the middle? Men traded wares – but women traded knowledge: what a new archaeological study tells us about PNG sea trade The excavation, curation, and research of the Gantangqing site were supported by National Cultural Heritage Administration (China), Yunnan Provincial Institute of Cultural Relics and Archaeology, Yuxi Municipal Bureau of Culture and Tourism, Chengjiang Municipal Bureau of Culture and Tourism, Australian Research Council (ARC) Discovery Projects, Strategic Priority Research Program of the Chinese Academy of Sciences, Hong Kong Research Grants Council (RGC), National Natural Science Foundation of China (NSFC).
Yahoo
9 hours ago
- Yahoo
Brii Biosciences Announces Licensing Agreement with Joincare Group for Rights to BRII-693 in Greater China
Joincare Group to lead the clinical development and commercialization of BRII-693 in Greater China Brii Biosciences retains ex-Greater China rights to address the global antimicrobial resistance threats and continues investment in other priority pipeline assets DURHAM, N.C. and BEIJING, July 3, 2025 /PRNewswire/ -- Brii Biosciences Limited ("Brii Bio," stock code: a biotechnology company developing therapies to improve patient health and choice across diseases with high unmet medical needs, today announced that it has entered into a license and technology transfer agreement with Joincare Pharmaceutical Group Industry Co., Ltd ("Joincare Group"). Joincare Group will obtain an exclusive license from Brii Bio for the research, development, and commercialization of BRII-693 in the Greater China region. Under the terms of the agreement, Joincare Group will assume full responsibility for the development, regulatory approval and commercialization of BRII-693 in Greater China. In return, Brii Bio has received an upfront payment and will receive additional development and commercial milestone payments upon certain future milestone events plus tiered royalties on net product sales. BRII-693 is a novel synthetic lipopeptide in development for the treatment of critically ill patients with multidrug- and extensively drug-resistant (MDR/XDR) gram-negative bacterial infections, particularly those caused by carbapenem-resistant Acinetobacter baumannii (CRAB), Pseudomonas aeruginosa (CRPA) and Enterobacterales (CRE). Discovered through iterative structural modifications of the polymyxin scaffold, BRII-693 was designed to enhance antibacterial potency while reducing the toxicity commonly associated with older polymyxin agents such as renal and neuro-toxicities. In phase 1 studies, BRII-693 demonstrated a favorable safety, tolerability, and PK profile in healthy non-Chinese and Chinese participants. Brii Bio received IND approval from CDE of NMPA for a Phase 1 PK bridging study in China supporting a future Phase 3 registrational trial in patients with hospital-acquired bacterial pneumonia/ventilator-associated bacterial pneumonia. Dr. Zhi Hong, Chairman and Chief Executive Officer of Brii Bio, commented: "The growing threat of antimicrobial resistance in Greater China underscores the urgency for novel hospital antibiotics. With Joincare Group's proven capabilities in manufacturing and commercializing hospital antibiotics, we found the ideal partner to accelerate the development and commercialization of BRII-693. This partnership enables us to deliver a critical care medicine to Chinese patients facing life threatening infections." Mr. Nanqi Lin, Chief Executive Officer of Joincare Group, stated, "The Company has a long-standing track record of excellence in innovative drug research and development, underpinned by deep scientific expertise and a robust R&D platform. Driven by Brii Bio's well-established R&D system, the BRII-693 project demonstrated strong innovation and scientific rigor. Early data showing encouraging results in terms of therapeutic potential, pharmacodynamics, and pharmacokinetics, suggesting BRII-693's high potential to become a best-in-class therapy to address the critical unmet clinical needs. We are confident in the clinical prospects of BRII-693. This collaboration further strengthened Joincare Group's strategic positioning in the anti-infection disease area. We look forward to launching this asset soon, providing patients with more high-quality treatment options." About BRII-693 BRII-693 is a novel synthetic lipopeptide in development for the treatment of critically ill patients with MDR/XDR gram-negative bacterial infections, especially carbapenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa. Brii Bio holds exclusive global rights to develop and commercialize BRII-693. About Brii Bio Brii Biosciences Limited ("Brii Bio", stock code: is a biotechnology company developing therapies to address major public health challenges where patients experience high unmet medical needs, limited choice and significant social stigmas. With a focus on infectious diseases, the Company is advancing a broad pipeline of unique therapeutic candidates with lead programs against hepatitis B virus (HBV) infection. The Company is led by a visionary and experienced leadership team and has operations in key biotech hubs, including Raleigh-Durham, the San Francisco Bay Area, Beijing and Shanghai. For more information, visit About Joincare Group Established in 1992, Joincare Group (Joincare Pharmaceutical Group Industry Co., Ltd) is an innovative scientific research-based integrated pharmaceutical group after many years of steady operation and rapid development. The group owns two major listed companies, Joincare and Livzon Pharmaceutical, as well as more than 20 major holding subsidiaries. The company has always adhered to the concept of scientific and technological innovation as the cornerstone, implementing a dual-driver strategy focused on innovative drugs and high-barrier complex formulation technology platforms, and has carried out rich pipeline layouts around respiratory, anti-infective, gastrointestinal, assisted reproduction, psychiatric, oncology and other areas of significant clinical needs, forming a rich and diversified product matrix and pipeline of drugs under development. Forward-looking Statements This contains the disclosure of some forward-looking statements. Except for statements of facts, all other statements can be regarded as forward-looking statements, that is, about our or our management's intentions, plans, beliefs, or expectations that will or may occur in the future. Such statements are assumptions and estimates made by our management based on its experience and knowledge of historical trends, current conditions, expected future development and other related factors. This forward-looking statement does not guarantee future performance, and actual results, development and business decisions may not match the expectations of the forward-looking statement. Our forward-looking statements are also subject to a large number of risks and uncertainties, which may affect our short-term and long-term performance. View original content to download multimedia: SOURCE Brii Biosciences Limited